All news from Transfusion Medicine

Rivaroxaban Reduces Blood Clots In Cancer Patients

Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly reduced VTE and VTE-related death for outpatient, at-risk cancer patients while they were taking the oral blood thinner.

New Tool to Find And Fight Most Dangerous Types Of Lymphoma

UK scientists have found a new way to identify people with the most aggressive types of lymphoma who are less likely to respond to standard drugs. Lymphomas are a form of cancer affecting white blood cells, and although these tumours looked the same as others under the microscope, the new test, called gene expression profiling showed that one in 10 patients in a trial were half as likely to be cured with existing treatments.